Bvf Partners L P/Il - Insider Trading & Ownership

Entity
Company
Location
44 Montgomery St., 40 Th Floor, San Francisco, California
Summary
The estimated value of insider holdings of Bvf Partners L P/Il is at least $57.2 M dollars as of June 28, 2024. Bvf Partners L P/Il is the Director, Other* of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $11.6 M. Bvf Partners L P/Il is the 10%+ Owner of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $10.9 M. Bvf Partners L P/Il is the Director, 10%+ Owner of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $9.26 M. Bvf Partners L P/Il is the 10%+ Owner of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $6.47 M. Bvf Partners L P/Il is the 10%+ Owner of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $3.86 M. Bvf Partners L P/Il is the 10%+ Owner of ESSA Pharma Inc. and owns shares of ESSA Pharma Inc. (EPIX) stock worth about $3.58 M. Bvf Partners L P/Il is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $2.96 M. Bvf Partners L P/Il is the 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $2.49 M. Bvf Partners L P/Il is the 10%+ Owner of Allakos Inc. and owns shares of Allakos Inc. (ALLK) stock worth about $2.14 M. Bvf Partners L P/Il is the Director, Other*, 10%+ Owner of XOMA Corp and owns shares of XOMA Corp (XOMA) stock worth about $1.91 M. Bvf Partners L P/Il is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $799 K. Bvf Partners L P/Il is the 10%+ Owner of PIERIS PHARMACEUTICALS, INC. and owns shares of PIERIS PHARMACEUTICALS, INC. (PIRS) stock worth about $633 K. Bvf Partners L P/Il is the 10%+ Owner of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $573 K.
All Insider Reports
All Insider Reports

Ownership of Bvf Partners L P/Il

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KYMR Kymera Therapeutics, Inc. Director, Other* $11.6 M +$30 M Jun 18, 2024
VSTM Verastem, Inc. 10%+ Owner $10.9 M Jan 25, 2022
OLMA Olema Pharmaceuticals, Inc. Director, 10%+ Owner $9.26 M +$14.8 M Jun 14, 2024
MRUS Merus N.V. 10%+ Owner $6.47 M Oct 7, 2021
FDMT 4D Molecular Therapeutics, Inc. 10%+ Owner $3.86 M Jun 16, 2022
EPIX ESSA Pharma Inc. 10%+ Owner $3.58 M Jul 11, 2022
RPTX Repare Therapeutics Inc. 10%+ Owner $2.96 M +$9.07 M Nov 15, 2023
THRD Third Harmonic Bio, Inc. 10%+ Owner $2.49 M Dec 20, 2022
ALLK Allakos Inc. 10%+ Owner $2.14 M Jan 16, 2024
XOMA, XOMAO XOMA Corp Director, Other*, 10%+ Owner $1.91 M May 17, 2023
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $799 K Jan 19, 2023
PIRS PIERIS PHARMACEUTICALS, INC. 10%+ Owner $633 K May 11, 2023
ELDN Eledon Pharmaceuticals, Inc. 10%+ Owner $573 K May 9, 2024
RAIN Rain Oncology Inc. Director, Other* $0 Jan 25, 2024
CTIC CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Jun 26, 2023
ENGN, ENGNW enGene Holdings Inc. 10%+ Owner Oct 31, 2023
MLTX MoonLake Immunotherapeutics Director, 10%+ Owner Jun 6, 2024
PNT POINT Biopharma Global Inc. Former 10% Owner -$214 M Dec 18, 2023
GPCR Structure Therapeutics Inc. 10%+ Owner May 10, 2023

Insider Transactions Reported by Bvf Partners L P/Il:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership